Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Mepolizumab and Physical Activity in Severe Asthma

View source ↗

Summary

This document reports an update on a clinical trial evaluating mepolizumab with physical activity in severe asthma; the study is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mepolizumab (Nucala) (mepolizumab)

Snippet

Sponsor: University Hospital, Lille | Conditions: Asthma, Asthma; Eosinophilic | Status: ACTIVE_NOT_RECRUITING